Regional Coronary Artery Disease & Heart Failure Symposium

April 12, 2018 · Ottawa Heart Institute

Regional Coronary Artery Disease & Heart Failure Symposium is open to all physicians and health care professionals within the Champlain LHIN.

Details

This interactive session will provide practitioners with an update on the latest best practice guidelines and technologies and therapies for diagnosing and treating Coronary Artery Disease (CAD) and Heart Failure. It will assist practitioners in developing strategies to apply this knowledge to the diagnosis, treatment and/or referral of patients with cardiovascular disease.

Sessions include Acute Coronary Syndrome (ACS), new approaches to revascularization and decision-making, optimal medical management and follow-up, women and CAD and diabetes and CAD. The last part of the day provides participants with an update on Heart Failure guidelines.

See the Symposium’s agenda.

Download the flyer (pdf)

Cost

Free. Space is limited and on a first-come, first-served basis.

Meals and refreshments provided.

Registration

Register online

Location

Ottawa Heart Institute
40 Ruskin Street
Foustanellas Auditorium (2nd Floor)

Map

Agenda

Session 1

At the end of these presentations, the participant will be able to:

  1. Apply the updated evidence-based ASC guidelines including new therapies in the management of the ACS patient after discharge.
  2. Define the evidence-based interventions for patients diagnosed with CAD.
  3. Comprehend new revascularization techniques and the decision making around elective CAD.
  4. Illustrate how diabetes leads to worsening CAD and highlight new diabetes therapies that impact the heart.
Time Topic Speaker(s)
8:30 a.m. - 8:50 a.m.  Registration/Coffee  
8:50 a.m. - 9 a.m. Opening Remarks H. Sherrard
9:00 a.m. - 9:30 a.m. Acute Coronary Syndrome (ACS) Dr. M. Le May
9:30 a.m. - 9:50 a.m. What’s New in the Percutaneous Coronary Intervention (PCI) World? Dr. AY. Chong
9:50 a.m. - 10:10 a.m. What’s New in Surgical Revascularization Dr. J. Grau
10:10 a.m. - 10:30 a.m. Elective CAD Decision Making Drs. AY Chong and D. Glineur
10:30 a.m. - 10:45 a.m. Coffee  
10:45 a.m. - 11:15 a.m. Post Revascularization Follow-up Dr. B. Hibbert
11:15 a.m. - 11:45 a.m. Optimal Medical Management for CAD Dr. M. Froeschl
11:45 a.m. - 12:15 p.m. Diabetes & CAD Dr. A. Arnaout
12:15 p.m. - 12:20 p.m. Closing Remarks & Evaluations H. Sherrard

Session 2

At the end of these presentations, the participant will be able to:

  1. Identify gender differences in cardiovascular pathophysiology and diagnosis and treatment implications.
  2. Recognize spontaneous coronary artery dissection as a cause of myocardial infarction in low risk, predominantly female, patients.
  3. Explain the relationship between depression and CAD and learn how to recognize depression in patients with CAD.
  4. Recognize when and when not to test and which test is most appropriate for your patient.
  5. Apply the updated evidence-based HF guidelines in practice.
Time Topic Speaker(s)
12:20 p.m. - 1:15 p.m. Registration/Lunch  
1:15 p.m. - 1:45 p.m. CAD in Women Dr. T. Coutinho
1:45 p.m. - 2:15 p.m. Spontaneous Coronary Artery Dissection (SCAD) Dr. T. Coutinho
2:15 p.m. - 2:45 p.m. Depression and CAD Dr. H. Tulloch
2:45 p.m. - 3 p.m. Coffee  
3 p.m. - 3:30 p.m. Right Test, Right Time, Right Patient Dr. B. Chow
3:30 p.m. - 4 p.m. Updated HF Guidelines I - Diagnosis/testing Dr. N. Ghosh
4 p.m. - 4:30 p.m. Updated HF Guidelines II - Novel Therapies Dr. L. Mielniczuk
4:30 p.m. - 4:35 p.m. Closing Remarks & Evaluations H. Sherrard

Share This